RxDoctor Payments Data

Tarunjeet Klair, MD

Transplant Surgery · New York, NYNPI 1275811580

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $965 of the $1,136 with a category attached, or 85.0%. 7 manufacturers reported payments, led by Organ Recovery Systems, Inc. at 28.8% of the total. Reporting peaked in 2020 at $327 and has fallen 58.5% since, to $136 in 2025. That places this record below the midpoint for transplant surgery clinicians in NY, where the typical reported total is $1,271.

$1,136in general payments, 2019–2025

Across 9 payments — averaging $126.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Organ Recovery Systems, Inc.$327
  • Intuitive Surgical$170
  • Fujifilm Healthcare Americas Corporation$167
  • Olympus America Inc.$150
  • Boston Scientific$136
  • Sanofi-aventis U.S. LLC$125
  • plus $61 from 1 others
$116,472in research payments, 2019–2025

Across 33 payments — averaging $3529.46 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Transmedics, Inc.$116K

What the payments were for

  • Food & beverage$96585%
  • Education$17015%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,136 in reported general payments places this provider in the 45th percentile of 72 transplant surgery providers in New York.

See all transplant surgery providers in New York

Medicare billing

Part B allowed, 2024
$85,833
Medicare patients
23
Services billed
86

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other transplant surgery in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →